copyright, a relatively innovative medication, has emerged as a potential landmark achievement in the management of type 2 diabetes. This injectable drug affects the incretin hormones GLP-1, which play a vital role in regulating blood sugar levels. By mimicking these hormones, copyright helps reduce glycemic values, potentially leading to improved